DE PLACIDO, SABINO
DE PLACIDO, SABINO
DIPARTIMENTO DI SANITA' PUBBLICA
FOLFOX-4 in pre-treated patients with advanced transitional cell carcinoma of the bladder.
2004 Giuseppe Di, Lorenzo; Riccardo, Autorino; Antonio, Giordano; Giuliano, Mario; Massimo, D'Armiento; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study.
2008 Di Lorenzo, G; Figg, Wd; Fossa, Sd; Mirone, Vincenzo; Autorino, R; Longo, Nicola; Imbimbo, Ciro; Perdonà, S; Giordano, A; Giuliano, Mario; Labianca, R; DE PLACIDO, Sabino
Phase 1/2 study of intravenous paclitaxel and oral cyclophosphamide in pretreated metastatic urothelial bladder cancer patients
2009 Di Lorenzo, G; Montesarchio, V; Autorino, R; Bellelli, T; Longo, N; Imbimbo, Ciro; Morelli, E; Giannarini, G; Mirone, Vincenzo; DE PLACIDO, Sabino
Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
2001 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Role of pegylated lyposomal doxorubicin (PLD) in systemic Kaposi's sarcoma: a systematic review
2006 DI TROLIO, R; DI LORENZO, G; Delfino, Mario; DE PLACIDO, Sabino
A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer.
2005 DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; DE LENA, M; Lorusso, V; Paradiso, A; D'Aprile, M; Pistillucci, G; Farris, A; Sarobba, Mg; Palazzo, S; Manzione, L; Adamo, V; Palmeri, S; Ferrau, F; Lauria, Rossella; Pagliarulo, C; Petrella, Giuseppe; Limite, Gennaro; Costanzo, Raffaele; Bianco, Ar; GOCSI COOPERATIVE, G. R. O. U. P.
MANAGEMENT OF GYNAECOMASTIA IN PATIENTS WITH PROSTATE CANCER: A SYSTEMATIC REVIEW.
2005 DI LORENZO, G; Autorino, R; Perdona, S; DE PLACIDO, Sabino
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
2003 Tortora, G; Caputo, R; Damiano, V; Melisi, D; Bianco, Roberto; Fontanini, G; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE; Ciardiello, F.
Role of chemotherapy in hormone – refractory prostate cancer. Old issues, recent advances and new perspectives.
2003 Autorino, R; DI LORENZO, G; Damiano, R; DE PLACIDO, Sabino; Darmiento, M.
RESULTS OF ADJUVANT TREATMENT IN BREAST CANCER WOMEN AGED MORE THAN 70: ITALIAN COOPERATIVE GROUP EXPERIENCE.
2002 Mustacchi, G; Ceccherini, R; Pluchinotta, A; DE MATTEIS, Maria Antonietta; Maiorino, L; Farris, A; Scanni, A; DE PLACIDO, Sabino
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy.
2004 Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, Vincenzo; Troiani, T; Melisi, D; DE VITA, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G.
Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
2005 Arpino, Grazia; Weiss, H; Lee, Av; Schiff, R; DE PLACIDO, Sabino; Osborne, Ck; Elledge, R. M.
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study.
2004 DE PLACIDO, Sabino; Scambia, G; DI VAGNO, G; Naglieri, E; Lombardi, Av; Biamonte, R; Marinaccio, M; Carteni, G; Manzione, L; Febbraro, A; DE MATTEIS, A; Gasparini, G; Valerio, Mr; Danese, S; Perrone, F; Lauria, Rossella; DE LAURENTIIS, Michelino; Greggi, S; Gallo, C; Pignata, S.
Pegylated liposomal doxorubicin in stage IVB mycosis fungoides
2005 DI LORENZO, G; DI TROLIO, R; Delfino, Mario; DE PLACIDO, Sabino
Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma.
2005 Damiano, V; Melisi, D; Bianco, C; Raben, D; Caputo, R; Fontanini, G; Bianco, Roberto; Ryan, A; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer.
2005 DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, C; Ciardiello, F; Tortora, Giampaolo; D'Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, Rossella; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Cost of insurance policies for investigator-initiated cancer clinical trials in Italy.
2005 Francesco, Perrone; Maurizio, Marangolo; Francesco Di, Costanzo; Giuseppe, Colucci; Lazzaro, Repettos; Marco, Merlano; DE PLACIDO, Sabino; Valter, Torri; Giuseppe, Comella; Roberto, Labianca; Valerio, Parisi; Ciro, Gallo
ZD1839 (Iressa): preclinical studies and pharmacology.
2002 Ciardiello, Fortunato; Tortora, Giampaolo; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE
Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.
2007 Arpino, Grazia; Carolina, Gutierrez; Heidi, Weiss; Mothaffar, Rimawi; Suleiman, Massarweh; Lavina, Bharwani; DE PLACIDO, Sabino; C., Kent Osborne; Rachel, Schiff
Re: Perabo FGE and Muller SC. New agents for treatment of advanced transitional cell carcinoma. Ann Oncol 2007; 18: 835-843.
2007 G., Di Lorenzo; DE PLACIDO, Sabino
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| FOLFOX-4 in pre-treated patients with advanced transitional cell carcinoma of the bladder. | 1.1 Articolo in rivista | 2004 | Giuseppe Di, Lorenzo; Riccardo, Autorino; Antonio, Giordano; Giuliano, Mario; Massimo, D'Armiento; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study. | 1.1 Articolo in rivista | 2008 | Di Lorenzo, G; Figg, Wd; Fossa, Sd; Mirone, Vincenzo; Autorino, R; Longo, Nicola; Imbimbo, Ciro; Perdonà, S; Giordano, A; Giuliano, Mario; Labianca, R; DE PLACIDO, Sabino | |
| Phase 1/2 study of intravenous paclitaxel and oral cyclophosphamide in pretreated metastatic urothelial bladder cancer patients | 1.1 Articolo in rivista | 2009 | Di Lorenzo, G; Montesarchio, V; Autorino, R; Bellelli, T; Longo, N; Imbimbo, Ciro; Morelli, E; Giannarini, G; Mirone, Vincenzo; DE PLACIDO, Sabino | |
| Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. | 1.1 Articolo in rivista | 2001 | Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo | |
| Role of pegylated lyposomal doxorubicin (PLD) in systemic Kaposi's sarcoma: a systematic review | 1.1 Articolo in rivista | 2006 | DI TROLIO, R; DI LORENZO, G; Delfino, Mario; DE PLACIDO, Sabino | |
| A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. | 1.1 Articolo in rivista | 2005 | DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; DE LENA, M; Lorusso, V; Paradiso, A; D'Aprile, M; Pistillucci, G; Farris, A; Sarobba, Mg; Palazzo, S; Manzione, L; Adamo, V; Palmeri, S; Ferrau, F; Lauria, Rossella; Pagliarulo, C; Petrella, Giuseppe; Limite, Gennaro; Costanzo, Raffaele; Bianco, Ar; GOCSI COOPERATIVE, G. R. O. U. P. | |
| MANAGEMENT OF GYNAECOMASTIA IN PATIENTS WITH PROSTATE CANCER: A SYSTEMATIC REVIEW. | 1.1 Articolo in rivista | 2005 | DI LORENZO, G; Autorino, R; Perdona, S; DE PLACIDO, Sabino | |
| Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. | 1.1 Articolo in rivista | 2003 | Tortora, G; Caputo, R; Damiano, V; Melisi, D; Bianco, Roberto; Fontanini, G; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE; Ciardiello, F. | |
| Role of chemotherapy in hormone – refractory prostate cancer. Old issues, recent advances and new perspectives. | 2.1 Contributo in volume (Capitolo o Saggio) | 2003 | Autorino, R; DI LORENZO, G; Damiano, R; DE PLACIDO, Sabino; Darmiento, M. | |
| RESULTS OF ADJUVANT TREATMENT IN BREAST CANCER WOMEN AGED MORE THAN 70: ITALIAN COOPERATIVE GROUP EXPERIENCE. | 2.1 Contributo in volume (Capitolo o Saggio) | 2002 | Mustacchi, G; Ceccherini, R; Pluchinotta, A; DE MATTEIS, Maria Antonietta; Maiorino, L; Farris, A; Scanni, A; DE PLACIDO, Sabino | |
| Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. | 1.1 Articolo in rivista | 2004 | Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, Vincenzo; Troiani, T; Melisi, D; DE VITA, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G. | |
| Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. | 1.1 Articolo in rivista | 2005 | Arpino, Grazia; Weiss, H; Lee, Av; Schiff, R; DE PLACIDO, Sabino; Osborne, Ck; Elledge, R. M. | |
| Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study. | 1.1 Articolo in rivista | 2004 | DE PLACIDO, Sabino; Scambia, G; DI VAGNO, G; Naglieri, E; Lombardi, Av; Biamonte, R; Marinaccio, M; Carteni, G; Manzione, L; Febbraro, A; DE MATTEIS, A; Gasparini, G; Valerio, Mr; Danese, S; Perrone, F; Lauria, Rossella; DE LAURENTIIS, Michelino; Greggi, S; Gallo, C; Pignata, S. | |
| Pegylated liposomal doxorubicin in stage IVB mycosis fungoides | 1.1 Articolo in rivista | 2005 | DI LORENZO, G; DI TROLIO, R; Delfino, Mario; DE PLACIDO, Sabino | |
| Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma. | 1.1 Articolo in rivista | 2005 | Damiano, V; Melisi, D; Bianco, C; Raben, D; Caputo, R; Fontanini, G; Bianco, Roberto; Ryan, A; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo | |
| A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer. | 1.1 Articolo in rivista | 2005 | DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, C; Ciardiello, F; Tortora, Giampaolo; D'Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, Rossella; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Cost of insurance policies for investigator-initiated cancer clinical trials in Italy. | 1.1 Articolo in rivista | 2005 | Francesco, Perrone; Maurizio, Marangolo; Francesco Di, Costanzo; Giuseppe, Colucci; Lazzaro, Repettos; Marco, Merlano; DE PLACIDO, Sabino; Valter, Torri; Giuseppe, Comella; Roberto, Labianca; Valerio, Parisi; Ciro, Gallo | |
| ZD1839 (Iressa): preclinical studies and pharmacology. | 1.1 Articolo in rivista | 2002 | Ciardiello, Fortunato; Tortora, Giampaolo; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE | |
| Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy. | 1.1 Articolo in rivista | 2007 | Arpino, Grazia; Carolina, Gutierrez; Heidi, Weiss; Mothaffar, Rimawi; Suleiman, Massarweh; Lavina, Bharwani; DE PLACIDO, Sabino; C., Kent Osborne; Rachel, Schiff | |
| Re: Perabo FGE and Muller SC. New agents for treatment of advanced transitional cell carcinoma. Ann Oncol 2007; 18: 835-843. | 1.1 Articolo in rivista | 2007 | G., Di Lorenzo; DE PLACIDO, Sabino |